HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.

Abstract
The farnesoid X receptor (FXR) is a bile acid (BA)-activated nuclear receptor that plays a major role in the regulation of BA and lipid metabolism. Recently, several studies have suggested a potential role of FXR in the control of hepatic carbohydrate metabolism, but its contribution to the maintenance of peripheral glucose homeostasis remains to be established. FXR-deficient mice display decreased adipose tissue mass, lower serum leptin concentrations, and elevated plasma free fatty acid levels. Glucose and insulin tolerance tests revealed that FXR deficiency is associated with impaired glucose tolerance and insulin resistance. Moreover, whole-body glucose disposal during a hyperinsulinemic euglycemic clamp is decreased in FXR-deficient mice. In parallel, FXR deficiency alters distal insulin signaling, as reflected by decreased insulin-dependent Akt phosphorylation in both white adipose tissue and skeletal muscle. Whereas FXR is not expressed in skeletal muscle, it was detected at a low level in white adipose tissue in vivo and induced during adipocyte differentiation in vitro. Moreover, mouse embryonic fibroblasts derived from FXR-deficient mice displayed impaired adipocyte differentiation, identifying a direct role for FXR in adipocyte function. Treatment of differentiated 3T3-L1 adipocytes with the FXR-specific synthetic agonist GW4064 enhanced insulin signaling and insulin-stimulated glucose uptake. Finally, treatment with GW4064 improved insulin resistance in genetically obese ob/ob mice in vivo. Although the underlying molecular mechanisms remain to be unraveled, these results clearly identify a novel role of FXR in the regulation of peripheral insulin sensitivity and adipocyte function. This unexpected function of FXR opens new perspectives for the treatment of type 2 diabetes.
AuthorsBertrand Cariou, Kirsten van Harmelen, Daniel Duran-Sandoval, Theo H van Dijk, Aldo Grefhorst, Mouaadh Abdelkarim, Sandrine Caron, Gérard Torpier, Jean-Charles Fruchart, Frank J Gonzalez, Folkert Kuipers, Bart Staels
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 281 Issue 16 Pg. 11039-49 (Apr 21 2006) ISSN: 0021-9258 [Print] United States
PMID16446356 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • DNA-Binding Proteins
  • Fatty Acids, Nonesterified
  • Insulin
  • Isoxazoles
  • Receptors, Cytoplasmic and Nuclear
  • Recombinant Proteins
  • Transcription Factors
  • farnesoid X-activated receptor
  • Glucose
  • GW 4064
Topics
  • 3T3-L1 Cells
  • Adipocytes (metabolism)
  • Adipose Tissue (metabolism)
  • Animals
  • Blood Glucose (metabolism)
  • Cell Differentiation
  • DNA-Binding Proteins (physiology)
  • Fatty Acids, Nonesterified (metabolism)
  • Female
  • Gene Expression Regulation
  • Glucose (metabolism)
  • Glucose Tolerance Test
  • Homeostasis
  • Homozygote
  • Insulin (metabolism)
  • Insulin Resistance
  • Isoxazoles (pharmacology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Obese
  • Mice, Transgenic
  • Muscle, Skeletal (metabolism)
  • Phosphorylation
  • Receptors, Cytoplasmic and Nuclear
  • Recombinant Proteins (chemistry)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction
  • Time Factors
  • Transcription Factors (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: